What does this research mean for the field?

Question

Accepted Answer

While quantitative BCR::ABL1 monitoring remains the cornerstone of chronic myeloid leukemia management, selective somatic NGS testing provides additional clinical utility when applied through a pragmatic interpretative framework. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

ELN 2025 and somatic NGS in CML: a pragmatic framework for selective testing and interpretation beyond BCR::ABL1

Key Points

Abstract

Cite This Study